Cantor Fitzgerald Reiterates Overweight on SI-BONE, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on SI-BONE (NASDAQ:SIBN) and maintained a $30 price target.
September 26, 2023 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst has reiterated an Overweight rating on SI-BONE and maintained a $30 price target.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for SI-BONE. The maintained price target of $30 suggests that the analyst believes the stock is still undervalued, which could lead to upward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100